NovoCure

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.

About NVCR

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. 

CEO
Asaf Danziger
CEOAsaf Danziger
Employees
1,167
Employees1,167
Headquarters
St. Helier, Jersey
HeadquartersSt. Helier, Jersey
Founded
2000
Founded2000
Employees
1,167
Employees1,167

NVCR Key Statistics

Market cap
8.10B
Market cap8.10B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
464.48K
Average volume464.48K
High today
$79.09
High today$79.09
Low today
$74.89
Low today$74.89
Open price
$76.24
Open price$76.24
Volume
211.57K
Volume211.57K
52 Week high
$124.35
52 Week high$124.35
52 Week low
$56.39
52 Week low$56.39

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
25%
Sell
25%

NVCR Earnings

-$0.25
-$0.16
-$0.07
$0.02
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Oct 27, Pre-Market
ActualExpected Oct 27, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.